Concepedia

Nicole Duclos

ND

10

Publications

1.1K

Citations

10

H-Index

2001

Active since

Affiliations

Brigham and Women's Hospital(Current)

Howard Hughes Medical Institute

Dana-Farber Cancer Institute

Harvard University

Novartis (Switzerland)

Nicole Duclos is an author at Brigham and Women's Hospital specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2001–2005

10

Publications

10

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Louise Kelly, Jin‐Chen Yu, Christina Boulton et al. · Cancer Cell · 2002 · 307 citations · Full text

, , +9

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease

Jan Cools, Elizabeth H. Stover, Christina Boulton et al. · Cancer Cell · 2003 · 216 citations · Full text

, , +8

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder

Jing Chen, Daniel J. DeAngelo, Jeffery L. Kutok et al. · Proceedings of the National Academy of Sciences · 2004 · 172 citations · Full text

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies

Jing Chen, Benjamin H. Lee, Ifor R. Williams et al. · Oncogene · 2005 · 91 citations

, , +7

FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model

Benjamin H. Lee, Ifor R. Williams, Ema Anastasiadou et al. · Oncogene · 2005 · 78 citations

, , +9

Rows per page

1–5 of 10